Company Filing History:
Years Active: 2025
Title: The Innovations of Sung Yong Won
Introduction
Sung Yong Won is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of immunology, particularly in the development of chimeric antigen receptors. His work focuses on enhancing the anticancer activity of immune cells, which has important implications for cancer treatment.
Latest Patents
Sung Yong Won holds a patent for a chimeric antigen receptor and natural killer cells expressing the same. This invention provides a chimeric antigen receptor (CAR) that includes an intracellular signaling domain featuring the whole or a portion of an OX40 ligand (CD252). This innovative approach has demonstrated excellent effects in increasing the anticancer activity of immune cells.
Career Highlights
Sung Yong Won is associated with Gc Cell Corporation, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, and he is recognized for his expertise in the field.
Collaborations
Some of his notable coworkers include Yu Kyeong Hwang and Sung Yoo Cho, who contribute to the collaborative efforts at Gc Cell Corporation.
Conclusion
Sung Yong Won's innovative work in developing chimeric antigen receptors represents a significant advancement in cancer immunotherapy. His contributions are vital for the future of cancer treatment and the enhancement of immune cell functionality.